BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Felbinac

4-biphenylylacetic acid ethyl ester [Supplementary Concept]

31+ PubMed studies analyzed · 6 RCTs · Evidence Score: 41.3

Research Domains

Felbinac has been studied across 10 research domains including 🔬 Inflammation, 🦴 Bone & Joint, ✨ Skin & Hair, 🧠 Focus & Attention, 💊 Pain. The primary research focus is 🔬 Inflammation with 65% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Felbinac, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Cefamandole
2 shared targets
Niflumic
3 shared targets
Oxaprozin
2 shared targets
sulindac
2 shared targets
Ceftriaxone
2 shared targets
Indomethacin
2 shared targets
gamma-Linolenic
2 shared targets
Febuxostat
2 shared targets
Dinoprostone
2 shared targets
amlexanox
2 shared targets
Loading evidence profile...

This evidence profile for Felbinac is generated deterministically from 31 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.